大行評級|招銀國際:重申中國財險“買入”評級及目標價11.7港元 新能源車保市場份額吸引
招銀國際發表研究報吿指,認為中國財險未來前景樂觀,因為該公司新能源汽車保險市場份額頗具吸引力,並且是行業內首家實現新能源汽車綜合成本率(CoR)低於100%的公司;家用車輛的增長在過去幾年中佔汽車保費的70%以上,以及隨着個人意外事故和意外健康(A&H)的擴大,非汽車結構得到改善。該行重申中國財險“買入”的投資評級及目標價11.7港元。該行預計2023財年中國財險將實現汽車和非汽車綜合成本率(CoR)97%及100%的指引。得益於7%總保費增長及 CoR 改善,該行預計2024年承保利潤將年增約12%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.